News Muncher - searching for pegylated

pegylated

Zydus Cadila's Pegylated Interferon alpha-2b drug, 'Virafin', has received Emergency Use Approval from DCGI, the Drugs Controller General of India. Pharma giant Zydus Cadila says its anti-viral drug Virafin can not only reduce the need for medical oxygen but also improve recovery time among Covid-19 patients. Earlier launched as PegiHep, the drug was being used to treat Hepatitis C. A …

Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India for additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19. Phase-III clinical trials with Pegylated Interferon Alpha 2b, which company sells under the brand name 'PegiHep' has shown promising results in treating COVID-19, Zydus Cadila said …

Gujarat-based drug manufacturer Zydus Cadila today said it has received approval from the Drugs Controller General of India to conduct Phase 3 clinical trials on its re-purposed drug that it hopes to use for Covid-19 treatment. The drug, Pegylated Interferon alpha-2b, 'PegiHepTM', is an approved drug that been in use since 2001 and is now being re-purposed to treat Covid-19 …

New Delhi: Drug firm Zydus Cadila on Thursday said it has successfully completed a phase 2 clinical trial In COVID-19 patients with its biological therapy, 'PegiHep', and it will now begin phase 3 clinical trial. In a regulatory filing, Zydus Cadila said "it has successfully completed a phase 2 clinical trial in COVID-19 patients with its biological therapy, Pegylated Interferon …